- Home
- PRLD vs LFT Comparison
PRLD vs LFT Comparison
Compare PRLD & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- LFT
- Stock Information
- Founded
- PRLD 2016
- LFT 2012
- Country
- PRLD United States
- LFT United States
- Employees
- PRLD N/A
- LFT N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- LFT Real Estate Investment Trusts
- Sector
- PRLD Health Care
- LFT Real Estate
- Exchange
- PRLD Nasdaq
- LFT Nasdaq
- Market Cap
- PRLD 69.1M
- LFT 82.2M
- IPO Year
- PRLD 2020
- LFT N/A
- Fundamental
- Price
- PRLD $1.36
- LFT $1.52
- Analyst Decision
- PRLD Strong Buy
- LFT Hold
- Analyst Count
- PRLD 3
- LFT 1
- Target Price
- PRLD $4.00
- LFT N/A
- AVG Volume (30 Days)
- PRLD 3.2M
- LFT 189.8K
- Earning Date
- PRLD 10-31-2025
- LFT 11-07-2025
- Dividend Yield
- PRLD N/A
- LFT 15.58%
- EPS Growth
- PRLD N/A
- LFT N/A
- EPS
- PRLD N/A
- LFT 0.18
- Revenue
- PRLD $7,000,000.00
- LFT $25,803,999.00
- Revenue This Year
- PRLD N/A
- LFT $124.75
- Revenue Next Year
- PRLD N/A
- LFT N/A
- P/E Ratio
- PRLD N/A
- LFT $8.56
- Revenue Growth
- PRLD N/A
- LFT N/A
- 52 Week Low
- PRLD $0.61
- LFT $1.50
- 52 Week High
- PRLD $4.22
- LFT $2.84
- Technical
- Relative Strength Index (RSI)
- PRLD 47.51
- LFT 19.13
- Support Level
- PRLD $1.43
- LFT $1.50
- Resistance Level
- PRLD $4.19
- LFT $1.75
- Average True Range (ATR)
- PRLD 0.40
- LFT 0.07
- MACD
- PRLD -0.01
- LFT -0.00
- Stochastic Oscillator
- PRLD 6.44
- LFT 7.69
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.